SCOPUS 정보 검색 플랫폼

Volumn 17, Issue 4, 2000, Pages 315-323

QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzyl-glycine hydroxamates using LFER model

(4) Roy, K a Pal, D K a De, A U a Sengupta, C a

a Flat No 2E 8 ^* (India)

Author keywords

Hansch analysis; Hydroxamates; LFER model; Matrix metalloproteinase inhibitors; QSAR

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; PHEYLSULFONYL N 4 NITROBENZYLGLYCINE HYDROXAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ACTIVITY; DRUG STRUCTURE; HYDROPHILICITY; LINEAR SYSTEM; LIPOPHILICITY; MULTIPLE REGRESSION; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; STEREOCHEMISTRY;

GLYCINE; HYDROXAMIC ACIDS; LINEAR ENERGY TRANSFER; MATRIX METALLOPROTEINASES; MODELS, CHEMICAL; NITROBENZOATES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034551794 PISSN: 10559612 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (12)

References (13)

1
- 0001426622
- Recent advances in matrix metalloproteinase inhibitor research and development
- (1998) Curr. Opin. Drug Discuss. , vol.1 , pp. 157-164
- Whittaker, M.¹ Brown, P.²

2
- 0001651169
- Design and therapeutic application of matrix metalloproteinase inhibitors
- (1999) Chem. Rev. , vol.99 , pp. 2735-2776
- Whittaker, M.¹ Floyd, C.D.² Brown, P.³ Gearing, A.J.H.⁴

3
- 0001493998
- Osteoarthritis
- Edited by Fauci, A. S., Braunwald, E., Isselbacher, K. J., Wilson, J. D., Martin, J. B., Kasper, D. L., Hauser, S. L., and Longo D. L.,; New York: McGraw-Hill
- (1998) Harrison's Principles of Internal Medicine , pp. 1936-1937
- Brandt, K.D.¹

4
- 0034719482
- Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors
- (2000) J. Med. Chem. , vol.43 , pp. 156-166
- O'Brien, P.M.¹ Ortwine, D.F.² Pavlovsky, A.G.³ Picard, J.A.⁴ Sliskovic, D.R.⁵ Roth, B.D.⁶ Dyer, R.D.⁷ Johnson, L.L.⁸ Man, C.F.⁹ Hallak, H.¹⁰

5
- 0034075487
- Protease inhibitors: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties
- (2000) J. Med. Chem. , vol.43 , pp. 1858-1865
- Scozzafava, A.¹ Supuran, C.T.²

6
- 0034609778
- Carbonic anhydrase and matrix metalloproteinase inhibitors: Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isoenzymes I, II and IV, and N-hydroxysulfonamides inhibit both theses zinc enzymes
- (2000) J. Med. Chem. , vol.43 , pp. 3677-3687
- Scozzafava, A.¹ Supuran, C.T.²

7
- 0034628448
- Protease inhibitors: Current status and future prospects
- (2000) J. Med. Chem. , vol.43 , pp. 305-341
- Leung, D.¹ Abbenante, G.² Fairlie, D.P.³

8
- 77956756060
- Matrix metalloproteinase inhibitors and cancer
- Bristol, J. A. (Ed.); Michigan: Academic Press
- (1998) Annual Reports in Medicinal Chemistry , vol.33 , pp. 131-140
- Summers, J.B.¹ Davidsen, S.K.²

9
- 0040914011
- ρ σ π Analysis: A method for the correlation of biological activity and chemical structure
- (1964) J. Am. Chem. Soc. , vol.86 , pp. 1616-1626
- Hansch, C.¹ Fujita, T.²

10
- 0003561150
- Amsterdam: Elsevier
- (1984) Theoretical Drug Design Methods , vol.7
- Rainer, F.¹

11
- 0000130397
- The quantitative analysis of structure-activity relationships
- Wolff, M. E. (Ed.), 5th edn.; New York: John Wiley & Sons
- Burger's Medicinal Chemistry and Drug Discovery , pp. 507-509
- Kubinyi, H.¹

12
- 0003633894
- New Delhi: Oxford & IBH Publishing Co. Pvt. Ltd
- (1967) Statistical Methods , pp. 381-418
- Snedecor, G.W.¹ Cochran, W.G.²

13
- 0006901839
- note

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.